Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
Tóm tắt
Human prostate cancers (PCa) express great variability in their ability to metastasize to bone. The identification of molecules associated with aggressive phenotypes will help to define PCa subsets and will ultimately lead to better treatment strategies. The chemokine stromal‐derived factor‐1 (SDF‐1 or CXCL12) and its receptor CXCR4 are now known to modulate the migration and survival of an increasing array of normal and malignant cell types including breast, pancreatic cancers, glioblastomas, and others. The present investigation extends our previous investigations by determining the expression of CXCR4 and CXCL12 in humans using high‐density tissue microarrays constructed from clinical samples obtained from a cohort of over 600 patients. These data demonstrate that CXCR4 protein expression is significantly elevated in localized and metastastic cancers. At the RNA level, human PCa tumors also express CXCR4 and message, but overall, they were not significantly different suggesting post‐transcriptional regulation of the receptor plays a major role in regulating protein expression. Similar observations were made for CXCL12 message, but in this case more CXCL12 message was expressed by metastastic lesions as compared to normal tissues. PCa cell lines also express CXCL12 mRNA, and regulate mRNA expression in response to CXCL12 and secrete biologically active protein. Furthermore, neutralizing antibody to CXCL12 decreased the proliferation of bone homing LNCaP C4‐2B and PC3 metastastic tumor cells. These investigations provide important new information pertaining to the molecular basis of how tumors may ‘home’ to bone, and the mechanisms that may account for their growth in selected end organs. © 2003 Wiley‐Liss, Inc.
Từ khóa
Tài liệu tham khảo
Begum NA, 1999, Reduced expression of the CXCR4 receptor mRNA in hepatocellular carcinoma and lack of inducibility of its ligand alpha‐chemokine hIRH/SDF1alpha/PBSF in vitro, Int J Oncol, 14, 927
Geldof AA, 1997, Models for cancer skeletal metastasis: A reappraisal of Batson's plexus, Anticancer Res, 17, 1535
Geldof AA, 1997, Models for cancer skeletal metastasis: A reappraisal of Batson's plexus, Anticancer Res, 17, 1535
GuiseTA.2002.How Metastases Home to Bone: The Attraction of Chemokines July 2002 Commentary on: Taichman RS Cooper C Keller ET Pienta KJ Taichman NS McCauley LK. Use of the stromal cell‐derived factor‐1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002 Mar 15;62(6):1832–1837. Internet Communication.
Korenchuk S, 2001, VCaP, a cell‐based model system of human prostate cancer, In Vivo, 15, 163
Koshiba T, 2000, Expression of stromal cell‐derived factor 1 and CXCR4 ligand–receptor system in pancreatic cancer: A possible role for tumor progression, Clin Cancer Res, 6, 3530
Koutsilieris M, 1993, Osteoblastic metastasis in advanced prostate cancer, Anticancer Res, 13, 443
Mitra P, 1999, CXCR4 mRNA expression in colon, esophageal, and gastric cancers and hepatitis C infected liver, Int J Oncol, 14, 917
Rempel SA, 2000, Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma, Clin Cancer Res, 6, 102
Rubin MA, 2000, Rapid (“warm”) autopsy study for procurement of metastatic prostate cancer, Clin Cancer Res, 6, 1038
Taichman RS, 2002, Use of the stromal cell‐derived factor‐1/CXCR4 pathway in prostate cancer metastasis to bone, Cancer Res, 62, 1832
Wang JF, 1998, The alpha‐chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion, Blood, 92, 756, 10.1182/blood.V92.3.756
Zhou Y, 2002, CXCR4 is a major chemokine receptor on glioma cells and mediates their survival, J Biol Chem, 206, 200